Abstract:Methotrexate is one of the most effective drugs that is commonly used in the treatment of cancer. However, its application is limited due to low solubility, high toxicity and rapid metabolism. Therefore, in the present study, worm-like polymeric nanoparticles as carrier of methotrexate were prepared using biodegradable copolymers (mPEG-PCL). The impact of nanoparticles' geometry on the loading, delivery and drug's anti-cancer activity was investigated. The di-block copolymer mPEG-PCL was being synthesized by a ring opening polymerization of ɛ-caprolactone in the presence of mPEG as the initiator and Sn(oct)2 as the catalyst. It was used for the preparation of worm-like micelles and coated with silica, so that their structures are stable after drying. The synthesized copolymers and nanoparticles were characterized by FTIR, HNMR, GPC, XRD, TGA, DLS, and FE-SEM analyses. The efficiencies of drug loading and release of nanoparticles as in vitro, was studied by high performance liquid chromatography. The MTT method was used to estimate the toxicity on MCF-7 cell category. The obtained results showed that the nanoparticles were worm-like particles with less than 150 nm diameter and about 1 µm length. The loading and encapsulation efficiencies of drug by the worm-like nanoparticles were 3.5 ± 0.14% and 65.6 ± 0.12%, respectively, while they were obtained as 2.1 ± 0.08% and 26 ± 0.10%, respectively, for spherical nanoparticles. The methotrexate diffusional behavior of worm-like nanoparticles was compared with that of the spherical ones. On the other hand, the anti-cancer activity of MTX-loaded nanoparticles was more than the free drug. The results of the MTT assay showed strong and dose-dependent inhibition of cell (MCF-7 category) growth by the nanoparticles compared with MTX. The inhibitory concentrations (IC50 i.e. reduction viability of cell to 50%) obtained for worm-like, spherical nanoparticles and free drug (incubation times 72 h) were 8.25 ± 0.20, 9.15 ± 0.17, 12.28 ± 0.15 µg/mL, respectively. It can be concluded that application of non-spherical nanoparticles is a better and more effective strategy for controlled and slow release of methotrexate in the treatment of cancer.

Preparation and Antitumor Activity of a Polymeric Derivative of Methotrexate

Enhanced Percutaneous Delivery of Methotrexate Using Micelles Prepared with Novel Cationic Amphipathic Material

Synthesis and in vitro evaluation of methotrexate conjugated O,N-carboxymethyl chitosan via peptidyl spacers

Polyamidoamine dendrimer conjugated chitosan nanoparticles for the delivery of methotrexate.

Methotrexate-conjugated to polymer quantum dot for cytotoxicity effect improved against MCF-7 and Hela cells

In situ grafting of PEG Acrylate on drugs with aliphatic hydroxyl functionalities via RAFT polymerization to synthesize drug/polymer conjugates with improved water solubility

Synthesis and performance of alpha, beta-poly [(2-hydroethyl)-D, L-aspartamide]-methotrexate and alpha, beta-poly [(2-hydroethyl)-D, L-aspartamide]-succinic-methotrexate

Enhanced Antitumor Efficacy by Methotrexate Conjugated Pluronic Mixed Micelles Against Kbv Multidrug Resistant Cancer

Supramolecular polymeric prodrug micelles for efficient anticancer drug delivery

Preparation and in Vitro Release of Methotrexate Complexation with PEGylated Dendrimers

Preparation and Characterization of PEGylated Poly-L-Lysine-Hydroxycamptothecin Nanoparticles Without and with Methotrexate

Synthesis, Characterization, and in Vivo Efficacy Evaluation of PGG–docetaxel Conjugate for Potential Cancer Chemotherapy

Enhanced Antitumor Efficacy of Poly(d, L-lactide-co-glycolide)-based Methotrexate-Loaded Implants on Sarcoma 180 Tumor-Bearing Mice

Pluronic Mixed Micelles Overcoming Methotrexate Multidrug Resistance: in Vitro and in Vivo Evaluation.

Antitumor Activity and Toxicological Properties of Doxorubicin Conjugated to [Alpha],[beta]-Poly[(2-hydroxyethyl)-l-aspartamide] Administered Intraperitoneally in Mice.

The Therapeutic Effect of Methotrexate-Conjugated Pluronic-Based Polymeric Micelles on the Folate Receptor-Rich Tumors Treatment

Self-Assembled, Redox-Sensitive, H-Shaped Pegylated Methotrexate Conjugates with High Drug-Carrying Capability for Intracellular Drug Delivery

PEGylated polyamidoamine dendrimer/methotrexate complex: pharmacokinetics and anti-tumor activity in normal and tumor-bearing rodents

Mitoxantrone-preloaded water-responsive phospholipid-amorphous calcium carbonate hybrid nanoparticles for targeted and effective cancer therapy.

Dehydroascorbic Acids-Modified Polymer Micelles Target Cancer Cells to Enhance Anti-Tumor Efficacy of Paclitaxel

Preparation of wormlike polymeric nanoparticles coated with silica for delivery of methotrexate and evaluation of anticancer activity against MCF7 cells